Nexien Biopharma Inc
Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in … Read more
Market Cap & Net Worth: Nexien Biopharma Inc (NXEN)
Nexien Biopharma Inc (PINK:NXEN) has a market capitalization of $990.81K ($990.81K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #45512 globally and #14303 in its home market, demonstrating a 40.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nexien Biopharma Inc's stock price $0.01 by its total outstanding shares 70772196 (70.77 Million).
Nexien Biopharma Inc Market Cap History: 2015 to 2025
Nexien Biopharma Inc's market capitalization history from 2015 to 2025. Data shows growth from $84.93K to $990.81K (30.20% CAGR).
Nexien Biopharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nexien Biopharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NXEN by Market Capitalization
Companies near Nexien Biopharma Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Nexien Biopharma Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Nexien Biopharma Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Nexien Biopharma Inc's market cap moved from $84.93K to $ 990.81K, with a yearly change of 30.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $990.81K | -0.71% |
| 2024 | $997.89K | -45.77% |
| 2023 | $1.84 Million | -55.93% |
| 2022 | $4.18 Million | -21.33% |
| 2021 | $5.31 Million | -15.73% |
| 2020 | $6.30 Million | +154.29% |
| 2019 | $2.48 Million | -83.29% |
| 2018 | $14.83 Million | -95.59% |
| 2017 | $336.17 Million | +11715.92% |
| 2016 | $2.85 Million | +3250.00% |
| 2015 | $84.93K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nexien Biopharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $990.81K USD |
| MoneyControl | $990.81K USD |
| MarketWatch | $990.81K USD |
| marketcap.company | $990.81K USD |
| Reuters | $990.81K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.